The relationship between the vascular responses to the peptides ranatensin and angiotensin.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D004357:Drug Synergism; D007263:Infusions, Parenteral; D009638:Norepinephrine / Q000494:pharmacology; D010455:Peptides / Q000008:administration & dosage / Q000302:isolation & purification / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011941:Receptors, Adrenergic; D012867:Skin / Q000032:analysis; D013618:Tachyphylaxis; D013997:Time Factors; D014439:Tyramine / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000494:pharmacology*
D010455:Peptides; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D009638:Norepinephrine; D014439:Tyramine